Procurement Summary
Country: Brazil
Summary: Acquisition of Polivalent Human Immunoglobulin 5 G Fa (*), Polivalent Human Immunoglobulin 2.5 G Fa, Human Immunoglobulin 6 G Iv Vial/Ampoule(*), Ropivacaine 7.5 Mg/Ml Injectable Solution Ampoule 20...
Deadline: 25 Jun 2026
Posting Date: 15 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143326958
Document Ref. No.: 90409/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Object: Electronic Auction - Acquisition of POLIVALENT HUMAN IMMUNOGLOBULIN 5 G FA (*), POLIVALENT HUMAN IMMUNOGLOBULIN 2.5 G FA, HUMAN IMMUNOGLOBULIN 6 G IV VIAL/AMPOULE(*), ROPIVACAINE 7.5 MG/ML INJECTABLE SOLUTION AMPOULE 20 ML, LEVOBUPIVACAINE 0.5% + EPINEPHRINE 9.1 MCG/ML SOL INJ FA 20ML, LEVETIRACETAM 100 MG/ML ORAL SOLUTION BOTTLE 150 ML (*), LEVETIRACETAM 100 MG/ML ORAL SOLUTION BOTTLE 100 ML (*), NEOMICIN+POLYMYXINAB+DEXAMETHASONE(0.5%+6000UI+0.1%)5 ML(*), CIPROFLOXACIN + DEXAMETHASONE 0.3% + 0.1% COL UASG Code: 92301 Notice from: 06/15/2026 from 08:00 to 17:59 Proposal Delivery: from 06/15/2026 at 08:00 HUMAN IMMUNOGLOBULIN, CONCENTRATION 5 G, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION + DILUENT Quantity: 13456 HUMAN IMMUNOGLOBULIN, CONCENTRATION 2.5 G, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION + DILUENT Quantity: 26912 HUMAN IMMUNOGLOBULIN, CONCENTRATION 6 G, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION + DILUENT Quantity: 11214 ROPIVACAINE HYCLORHYDRATE, DOSAGE 0.75%, INJECTABLE SOLUTION PRESENTATION Quantity: 20858 LEVOBUPIVACAINE HYCLORHYDRATE, COMPOSITION ASSOCIATED WITH EPINEPHRINE BITARTART, CONCENTRATION 0.5% + 9.1MCG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 20858 LEVETIRACETAM, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION Quantity: 2170 LEVETIRACETAM, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION Quantity: 3260 POLYMYXIN B, COMPOSITION ASSOCIATED WITH NEOMICIN AND DEXAMETHASONE, CONCENTRATION 6, 000 IU + 3.5 MG + 1 MG/ML, FORM PHARMACEUTICAL OPHTHALMIC SUSPENSION Quantity: 11912 CIPROFLOXACIN HYCLORHYDRATE, ACTIVE INGREDIENT ASSOCIATED WITH DEXAMETHASONE, DOSAGE 3.5 MG + 1 MG/ML, PRESENTATION OF OPHTHALMIC SOLUTION Quantity: 11912 TOBRAMICIN, COMPOSITION ASSOCIATED WITH DEXAMETHASONE, CONCENTRATION 3 MG + 1 MG/ML, PHARMACEUTICAL FORM OPHTHALMIC SUSPENSION Quantity: 11912
Documents
Tender Notice